For decades, cancer immunotherapy has focused primarily on CD8 + cytotoxic T lymphocytes as the main executors of tumor cell killing. However, growing clinical and single-cell sequencing evidence ...
This TCR was then isolated and artificially expressed in other CD4 T cells. We then evaluated the effectiveness of these engineered cells against cancer cells, both in vitro and in animal models. The ...
Abnormal expansion of PD-1+ T lymphocytes may be a sign of lupus nephritis onset in patients with SLE. Elevated PD-1+CD4+ T cells represent an independent risk factor for lupus nephritis (LN) and may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results